Agenda
VEA Newport Beach, A Marriott Resort & Spa
900 Newport Center Dr. Newport Beach, CA 92660
Explore What’s Next: Cardiovascular Tech Forum 2024 Agenda Coming Soon!
Get ready for CTF 2024 on Thursday, September 12th! While the 2024 agenda is under wraps, dive into the excitement of our 2023 Forum, where pioneers and visionaries shaped the future of cardiovascular health. Stay tuned for an even more compelling 2024 agenda, featuring cutting-edge advancements, dynamic speakers, and interactive sessions that redefine cardiovascular technology. Relive the 2023 highlights and prepare to embark on a journey into the future of cardiovascular care. The Cardiovascular Tech Forum 2024 agenda is coming soon – we can’t wait to share it with you!
Friday, September 15, 2023
7:30 – 8:00 am PST
EXPERIENCE
Registration
8:00 – 8:45 am PST
EXPERIENCE
Partnership Pursuit (Invite Only)
9:00 – 9:15 am
OPENING
Opening Remarks
Cheryl Wood, Senior Event Manager, Octane
Bill Carpou, CEO, Octane
Maria Berkman, MD, Head of MedTech, Broadview Ventures
9:15 – 9:40 am
OPENING
Opening Keynote
Todd Brinton, MD, Chief Scientific Officer, Edwards Lifesciences; Founder & Medical Director, Shockwave
9:40 – 10:20 am
PANEL
Innovations in Heart Failure Treatment
Defining the current needs. What are the most modern and efficient device products available in the market today? How are we advancing treatments in heart failure? What steps do you need to take in what order on the innovation pathway to new treatments? How do you define ownership and commercialize within your own company? When is the right time to approach funding to attract investor dollars and how to approach investors?
Dipti Itchhaporia, MD, FACC, Director of Disease Management, Hoag Heart and Vascular Institute (Moderator)
Terri Burke, Venture Partner, Epidarex Capital
Andrew Douglas, Partner, Knobbe Martens
Fabio M. Sagebin, MD, Surgical Director of Advanced Heart Failure and Mechanical Circulatory Support, UCI Medical Center
William C. Wilson, MD, MA, Executive VP, Clinical Operations and Medical Affairs, Past CMO at Masimo and UCI
10:20 – 10:35 am
EXPERIENCE
Networking Break
10:35 – 11:20 am
PANEL
Pediatric Innovation Development
Discussing the unique opportunities that are available when innovating for the pediatric population with a focus on human-centered design. How do the assumptions in the adult medical innovation pathway vary within pediatrics? Demonstrating the compelling value of ROI within pediatrics from all of the constituents. How do we accelerate pediatric innovation through investing models and collaborative initiatives?
Beverly Tang, Ph.D., CEO, Starlight Cardiovascular
11:20 am – 12:00 pm PT
PANEL
Changing the Trajectory of Heart Health Globally
How do we meet the increasing and changing needs with current resource constraints? How do we accelerate the speed of treatment or even more efficiently improve preventative care? How prevalent is AI in international care?
Celine Martin, Company Group Chairman, Cardiovascular and Specialty Solutions Group, Johnson & Johnson (Moderator)
Mazen Albaghdadi, MD, Director of Cardiac Catheterization Laboratory, Associate Director Cardiology Fellowship at the Naples Heart Institute; Medical Director of Madaktari Africa
Ramin Mousavi, President & CEO, CathWorks
Lars Sondergaard, MD, DMSc, FESC, Divisional Vice-President, Medical Affairs, Chief Medical Officer, Abbott Structural Heart
Cynthia Yee, Principal, Vensana Capital
12:00 – 1:00 pm PT
EXPERIENCE
Networking Lunch
1:00 pm – 1:45 pm
PANEL
Aortic Disease
Steve Hanle, Shareholder, Stradling (Moderator)
Shivanth Bhaskaran, Vice President Global Marketing, Aortic, Medtronic
1:45 – 2:45 pm
PANEL
First-in-Humans
First-in-human trials serve as the link to advance new promising innovations from preclinical studies to initial human testing. What is the best pathway to first-in-human studies? How do you apply for first-in-humans in the United States? What are the pitfalls to avoid? Also, how are patient preferences factored into Clinical Studies in Cardiovascular Medicine? How are we taking into consideration the patient’s voice?
Jeff Daurity, Senior Director, Clinical Strategy and Operationalization, ICON (Moderator)
Adam Berman, CEO, Alleviant Medical, Inc.
William E Cohn, MD, Executive Director for the Center of Device Innovation at the Texas Medical Center
Saibal Kar, MD, Director of Structural Heart Disease and Research at HCA Healthcare
Arshad Quadri, MD, inQB8 Medical Technologies
2:45 – 3:15 pm
EXPERIENCE
Networking Break
3:15 – 3:45 pm
AWARD & KEYNOTE
Award & Keynote
Presented by Octane’s CEO, Bill Carpou, and inQBB Medical Technologies CEO, Dr. Arshad Quadri to:
William E Cohn, MD
3:45 – 5:15 pm
COMPANY PRESENTATIONS
Capital and Growth Presenting Companies
Octane portfolio companies that have graduated from Octane’s LaunchPad SBDC accelerator will pitch their products to our investor ecosystem with key strategics and physicians.
Michael Hill, Managing Director, Capital Assist
Dave Beck, General Manager, Haystax.ai
Presenting Companies
Total Flow Medical
Stimore Medical Devices
SoundCath
ImaCor
Relief Cardiovascular
Judges
Haleh Armian, MSc, Director of Biomedical Innovation Ventures, Hoag
Duncan Fatkin, Chief Commercial Officer, Beyond Air Inc.
Virginia Giddings, PhD, Vice President of Exploration, Edwards Lifesciences
Capital and Growth Awards and Closing Comments
Carol DiStanislao, Managing Director, Capital and Growth
5:15 – 8:00 pm PT
Women Leaders of Octane Quarterly Meeting (April 2024)
VirtualPlease join Women Leaders of Octane for our virtual quarterly meeting, Wednesday, April 17 from 12 – 1 pm PST, featuring our Spotlight Thought Leader, Sabina Pons, Managing Director, Growth […]
OC Innovation Week: Opening Reception
UCI Beall Applied Innovation 5270 California Ave # 100, Irvine, CAJoin us for the grand kickoff of OC Innovation Week at our Opening Reception, where excitement and innovation converge.